Form 4: HealthEquity Executive James M. Lucania Sells Shares to Cover Tax Obligations

HealthEquity's EVP & CFO, James M. Lucania, disposed of 1,848 shares of common stock on January 7, 2025, to cover tax obligations.

Summary

• James M. Lucania, the EVP & CFO of HealthEquity, Inc., sold 1,848 shares of common stock on January 7, 2025.
• The sale was executed at a price of $97.5445 per share.
• This transaction was done to cover tax obligations related to the vesting of restricted stock units.
• Following the transaction, Mr. Lucania beneficially owns 76,295 shares of HealthEquity common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is typical for executives who receive stock-based compensation.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are common across publicly traded companies.
• The sale is consistent with standard practices for executives managing their equity compensation.
• Similar filings are regularly seen from executives at companies like Teladoc Health and Livongo, which also operate in the healthcare technology space.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

HealthEquity, James M. Lucania, stock sale, insider trading, Form 4, executive compensation, tax obligations